11 completed, 8 unknown, 2 enrolling by invitation, 2 not yet recruiting. 9 Not applicable, 8 Phase 4, 4 Phase 2, 2 Phase 1, 1 Phase 3.
Follow bismuth tripotassium dicitrate: new trials by email Literature Review of bismuth tripotassium dicitrate trials Research Report on bismuth tripotassium dicitrate
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Metronidazole- Versus Tinidazole-Based Bismuth Quadruple Therapy for Helicobacter Pylori Eradication Metronidazole, Tinidazole 500mg, tetracyline - Helicobacter Pylori Infection | Not applicable | Not yet recruiting | University of Medicine and Pharmacy at Ho Chi Minh City | 600 | 2026-07-27 | 2026-08-05 |
| Prospective Study of Frontline Antibiotics Therapy in the Treatment of Early-stage HP-negative Gastric MALT Lymphoma Esomeprazole, Bismuth tripotassium dicitrate, Tetracycline, and Metronidazole - MALT Lymphoma of Stomach | Phase 2 | Not yet recruiting | National Taiwan University Hospital | 40 | 2025-09-01 | 2025-08-27 |
| Perioperative Oxaliplatin With S-1 Combined H. Pylori Eradication in the Management of Locally Advanced Gastric Cancer Oxaliplatin With S-1 (SOX) Combined H. Pylori Eradication (Amoxicillin + clarithromycin + omeprazole + colloidal bismuth subcitrate), Oxaliplatin With S-1 （SOX） - Chemotherapy Effect | Phase 2 | Recruiting | Sixth Affiliated Hospital, Sun Yat-sen University | 198 | 2024-12-31 | 2026-08-06 |
| Optimal Duration of Bismuth Quadruple Therapy for Helicobacter Pylori Eradication in Females As Compared with Males Drug: Bismuth Subcitrate 120 MG Oral Tablet, Esomeprazole 40mg, Metronidazole 250 MG - Helicobacter Pylori Infection, Sex | Phase 4 | Enrolling by invitation | National Cheng-Kung University Hospital | 661 | 2024-07-09 | 2024-11-07 |
| Feasibility Study of the Proposed Test-and-treat Screening Program in Younger Participants With H. Pylori Infection Bismuth Subcitrate, Esomeprazole, Metronidazole - Helicobacter Pylori Infection | Unknown | National Institute of Public Health, Slovenia | 2000 | 2024-02-01 | 2024-02-09 | |
| Bismuth Quadruple Therapy Versus Standard Triple Therapy Bismuth Subcitrate - Helicobacter Pylori Infection | Phase 4 | Unknown | University Medical Centre Ljubljana | 216 | 2022-03-03 | 2023-11-22 |
| ILTHPI - Comparison of Medicament Containing Tetracycline, Metronidazole, Bismuth Versus Amoxicillin, Metronidazole, Clarithromycin Tetracycline, Metronidazole, Bismuth subcitrate, Amoxicillin, Metronidazole, Clarithromycin - Helicobacter Pylori Infection | Phase 4 | Completed | Mackay Memorial Hospital | 104 | 2021-04-19 | 2023-01-04 |
| Prospective Randomised Trial of First and Second Line Treatments of RCT of First and Second Line H Pylori Treatments in Slovenia Esomeprazole 40mg, Clarithromycin 500 mg, Metronidazole 400 mg,, Esomeprazole 40mg, Bismuth subcitrate 120 mg, Amoxicillin 500 mg, Metronidazole 400 mg, Esomeprazole 40mg, Amoxicillin 500 mg, Levofloxacin 500 mg - Helicobacter Pylori Infection, Eradication Treatments | Not applicable | Unknown | Slovenian Society for Gastroenterology and Hepatology | 560 | 2020-05-10 | 2020-04-24 |
| The Efficacy of 10-day and 14-day Bismuth-based Quadruple Therapy in First-line H. Pylori Eradication Bismuth Subcitrate 120 MG Oral Tablet, Lactobacillus acidophilus and Bifidobacterium lactis Bb12, Esomeprazole 40mg - Helicobacter Pylori Infection, Dysbiosis | Phase 4 | Enrolling by invitation | National Cheng-Kung University Hospital | 312 | 2020-05-06 | 2024-06-24 |
| Non-invasive Test-guided Tailored Therapy Versus Empiric Treatment for Helicobacter Pylori Infection. Pantoprazole 40mg, Amoxicillin 1000 MG, Clarithromycin 500mg - Helicobacter Pylori Infection, Antibiotic Resistant Infection | Phase 3 | Unknown | University of Bari | 362 | 2020-01-14 | 2021-01-12 |
| Comparing the Efficacy of 10-day Reverse Hybrid Therapy and 10-day Triple Therapy Plus Bismuth Therapy. (panto+amox+clar+metr)+(panto+amox), pantoprazole+bismuth+amox+clar - Helicobacter Pylori Infection | Not applicable | Unknown | Kaohsiung Veterans General Hospital. | 440 | 2020-01-01 | 2020-09-28 |
| A Comparison of High-dose Dual Therapy and Half-dose Clarithromycin-containing Bismuth Quadruple Therapy for H.P Eradication in Elderly Patients Lansoprazole, Amoxicillin, Lansoprazole, Amoxicillin,Clarithromycin and Bismuth subcitrate - Helicobacter Pylori | Phase 4 | Unknown | Shandong University | 100 | 2019-09-20 | 2019-09-24 |
| Evaluate the PK of Multiple Oral Doses of Tegoprazan, Metronidazole, Tetracycline and Bismuth in Healthy Volunteers Tegoprazan, Metronidazole, Tetracycline - Healthy | Phase 1 | Completed | HK inno.N Corporation | 32 | 2019-01-17 | 2019-08-28 |
| A Study To Assess The Efficacy And Safety Of Bismuth Tripotassium Dicitrate (De-Nol) In Combination With Pantoprazole And Pantoprazole Monotherapy In Treatment Of Subjects With Nonsteroidal Anti-Inflammatory Drugs (NSAID)-Induced Gastropathy bismuth tripotassium dicitrate, pantoprazole - NSAID-induced Gastropathy | Phase 4 | Terminated | Astellas Pharma Europe B.V. | 9 | 2017-03-03 | 2017-09-21 |
| Comparing the Efficacy of 14-day Reverse Hybrid Therapy and 14-day Triple Therapy Plus Bismuth Therapy triple therapy plus bismuth therapy, reverse hybrid therapy - Helicobacter Pylori Infection | Not applicable | Unknown | Kaohsiung Veterans General Hospital. | 440 | 2017-01-01 | 2019-03-14 |
| TAK-438 Bismuth Drug Interaction Study Clarithromycin, Amoxicillin, Tripotassium bismuth dicitrate - Helicobacter Pylori | Phase 1 | Completed | Takeda | 30 | 2016-09-05 | 2019-01-03 |
| Doxycycline- and Furazolidone-containing Quadruple Regimen is Superior of Tailored Therapy Doxycycline, Furazolidone, Esomeprazole - Helicobacter Pylori Infection | Phase 4 | Unknown | Sir Run Run Shaw Hospital | 300 | 2016-02-01 | 2018-09-05 |
| Comparing the Efficacy of Reverse Hybrid Therapy and Bismuth Quadruple Therapy pantoprazole+bismuth+tetra+metro, (panto+amox+clar+metr)+(panto+amox) - Helicobacter Pylori Infection | Not applicable | Completed | Kaohsiung Veterans General Hospital. | 352 | 2015-02-01 | 2019-06-10 |
| Comparison of Hybrid and Bismuth Quadruple Therapies for Helicobacter Pylori Eradication Bismuth quadruple therapy, Hybrid therapy - Helicobacter Pylori Infection | Not applicable | Completed | Kaohsiung Veterans General Hospital. | 330 | 2013-07-01 | 2017-11-24 |
| Adding Bismuth to Rabeprazole-based First-line Triple Therapy Does Not Improve the Eradication of Helicobacter Pylori RAK therapy, RBAK therapy - Helicobacter Pylori Infection | Phase 4 | Completed | Kaohsiung Medical University Chung-Ho Memorial Hospital | 162 | 2013-04-01 | 2017-04-24 |
Showing 20 of 25. Sign in to see all of them.
Lymphoma, B-Cell, Marginal Zone (2) · Coitus (1) · Digestive System Diseases (1) · Drug-Related Side Effects and Adverse Reactions (1) · Dysbiosis (1) · Fatty Liver (1) · Infections (1) · Insulin Resistance (1) · Leukemia, Lymphocytic, Chronic, B-Cell (1) · Liver Diseases (1) · Lymphoma (1) · Stomach Neoplasms (1)
Kaohsiung Veterans General Hospital. (5) · National Cheng-Kung University Hospital (2) · Aga Khan University (1) · Astellas Pharma Europe B.V. (1) · European Organisation for Research and Treatment of Cancer - EORTC (1) · HK inno.N Corporation (1) · Kaohsiung Medical University Chung-Ho Memorial Hospital (1) · Mackay Memorial Hospital (1) · National Institute of Public Health, Slovenia (1) · National Taiwan University Hospital (1) · Shandong University (1) · Sir Run Run Shaw Hospital (1) · Sixth Affiliated Hospital, Sun Yat-sen University (1) · Slovenian Society for Gastroenterology and Hepatology (1) · Takeda (1)
Taiwan (8) · China (3) · Slovenia (3) · South Korea (2) · Hong Kong (1) · Iran (1) · Italy (1) · Pakistan (1) · Russia (1) · United Kingdom (1) · Vietnam (1)
Ping-I Hsu, Bachelor (3) · Feng-Woei Tsay, Bachelor (2) · Hsiu-Chi Cheng, MD, PhD (1) · Hsiu-Chi Cheng, PhD (1) · I-Chen Wu, MD, PhD (1) · Ivan FN Hung, MD FRCP (1) · John W. Sweetenham, MD (1) · Lei Lian, Ph.D (1) · Mariabeatrice Principi, Prof. (1) · Min-Gul Kim, MD (1)
PMID 19058002, PMID 21188333, PMID 22958155, PMID 24295850, PMID 25801708, PMID 27144617, PMID 27687850, PMID 27707777, PMID 28541262, PMID 28653787, PMID 28807915, PMID 29609070, PMID 30038469, PMID 33637332, PMID 36463082, PMID 38500841, PMID 41830631